K.o slashed.ge, Denmark

Leif No slashedrskov-Lauridsen


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Leif No Slashedrskov-Lauridsen

Introduction: Leif No Slashedrskov-Lauridsen, based in K.O Slashed.ge, Denmark, has made significant contributions to the field of biotechnology. With a focus on enzyme engineering, Leif's inventive work is exemplified in his patent regarding bacterial alkaline protease mutations. His research has the potential to enhance various applications in enzymatic processes.

Latest Patents: Leif No Slashedrskov-Lauridsen holds a patent titled "Useful mutations of bacterial alkaline protease." This invention is centered around mutations of the subtilisin gene, which lead to modifications in the chemical characteristics of the subtilisin enzyme. The described mutations occur at specific nucleic acid sites of the subtilisin gene and yield mutant enzymes with advanced properties, including increased stability to oxidation, augmented proteolytic activity, and improved washability. Additionally, this patent includes critical amino acid and DNA sequences for two proteases derived from Bacillus lentus variants, specifically subtilisin 147 and subtilisin 309, along with the mutations and corresponding variants of these genes.

Career Highlights: Leif has established his professional journey at Novo Nordisk A/S, a leading global healthcare company. His commitment to research and development in enzymatic applications underscores his pivotal role in advancing biotechnology. Through innovation and meticulous research, Leif has not only contributed to the scientific community but also enhanced the practical application of enzymes in various industries.

Collaborations: Leif No Slashedrskov-Lauridsen has collaborated with notable colleagues such as Sven Hastrup and Sven Branner. These professional relationships foster a collaborative environment aimed at driving meaningful advancements in enzyme technology and biotechnology, amplifying the impact of their combined expertise.

Conclusion: With his patent and ongoing research at Novo Nordisk A/S, Leif No Slashedrskov-Lauridsen exemplifies the spirit of innovation in biotechnology. His work with bacterial alkaline protease mutations demonstrates the potential for new and improved enzymatic solutions, paving the way for future discoveries in the field. As a key player in his domain, Leif continues to inspire innovation and collaboration among his peers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…